Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 65

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 65
---
 proponent solely to advise it that, in accordance with this Agreement, the Company can only enter into discussions or negotiations with a party in accordance with Article 6 of this Agreement, and for no other 
 purpose.                                                                                                                                                                                                                                                  |

| 6.2 | Responding to an Acquisition Proposal and Right to Match |

| (a) | Notwithstanding Section 6.1(a) or any other provision of this Agreement to the contrary, if after the date                                                                                                                                                
 hereof the Company or any of its Representatives receives from a person a written Acquisition Proposal (including, for greater certainty, an amendment, change or modification to an Acquisition Proposal made prior to the date hereof), the Company and 
 its Representatives may (x) contact the person making such Acquisition Proposal and its Representatives for the purpose of clarifying the terms and conditions of such Acquisition Proposal, and (y) engage in or participate in discussions or           
 negotiations with such person regarding such Acquisition Proposal, and may provide copies of, access to or disclosure of confidential information, properties, facilities, or books and records of the Company or the Subsidiary, if and only if, in the  
 case of clause (y):                                                                                                                                                                                                                                       |

| (i) | the Board of Directors determines in good faith, after consultation with its outside legal counsel and                                       
 financial advisors, that such Acquisition Proposal constitutes or would reasonably be expected to constitute or lead to a Superior Proposal; |

| (ii) | such person was not restricted from making such Acquisition Proposal pursuant to an existing confidentiality, 
 standstill or similar restriction;                                                                            |

| (iii) | the Company has been, and continues to be, in compliance with its obligations under this Article 6; |

| (iv) | the Company promptly provides the Purchaser with prior written notice stating the Company’s intention to 
 participate in such discussions or negotiations and to provide such copies, access or disclosure;        |

| (v) | the Company enters into an Acceptable Confidentiality Agreement with such person, and the Company provides a                                                                                                                             
 copy of such agreement to the Purchaser promptly following its execution and the Purchaser is promptly provided with all information provided to such person (to the extent not previously provided to the Purchaser) via the Data Room. |

- 37 -

| (b) | Notwithstanding Section 6.1(a) or any other provision of this Agreement, if after the date hereof the                                                                                                                                        
 Company receives an Acquisition Proposal that constitutes a Superior Proposal, the Company may (subject to compliance